BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 4183680)

  • 21. The concentrations of the fourth component of complement and of the C1 inactivator in synovial fluid from arthritic patients.
    Hedberg H; Laurell AB
    Clin Exp Immunol; 1972 Jun; 11(2):201-7. PubMed ID: 5040309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Behavior of C'3-concentration (beta-la-globulin) in inflammatory rheumatic diseases].
    Klein G
    Z Rheumaforsch; 1971; 30(3):104-8. PubMed ID: 4102837
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of gamma globulin complexes in rheumatoid arthritis.
    Vaughan JH; Morgan ES; Jacox RR
    Trans Assoc Am Physicians; 1968; 81():231-9. PubMed ID: 4181122
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune complexes and complement in rheumatoid arthritis.
    Lambert PH; Casali P; Nydegger U
    Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum and synovial fluid osteocalcin in rheumatic diseases.
    Mattei JP; Ferrera V; Boutsen Y; Franceschi JP; Botti D; De Boissezon C; Kaphan G; Roux H
    Int J Clin Pharmacol Res; 1992; 12(3):103-7. PubMed ID: 1473875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.
    Müllerèberhard HJ; Dalmasso AP; Calcott MA
    J Exp Med; 1966 Jan; 123(1):33-54. PubMed ID: 4159289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseases.
    March RE; Reeback JS; Holborow EJ; Jones VE; Jacoby RK
    Clin Exp Immunol; 1982 Jun; 48(3):555-60. PubMed ID: 6981473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erysipelas arthritis in swine: concentrations of complement and third component of complement in synovia.
    Timoney JF
    Am J Vet Res; 1976 Jan; 37(1):5-8. PubMed ID: 1247196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune complex activation of neutrophils and enhancement of the activation by rheumatoid factor and complement.
    Gale RJ; Nikoloutsopoulos A; Bradley J; Roberts-Thomson PJ
    J Rheumatol; 1985 Feb; 12(1):21-6. PubMed ID: 2580091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical significance of synovial fluid examination].
    Yu MX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Aug; 11(4):274-7. PubMed ID: 2532973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.
    Hedberg H; Lundh B; Laurell AB
    Clin Exp Immunol; 1970 May; 6(5):707-12. PubMed ID: 5477926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixation of the first component of complement (C'la) by human antibodies.
    Rosse WF
    J Clin Invest; 1969 Nov; 47(11):2430-45. PubMed ID: 4180276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A plasmin-split fragment of C'3 as a new chemotactic factor.
    Ward PA
    J Exp Med; 1967 Aug; 126(2):189-206. PubMed ID: 4226271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of human lymphocyte transformation by aggregated human gamma globulin.
    Kinsella TD
    J Clin Invest; 1974 Apr; 53(4):1108-14. PubMed ID: 4131162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
    Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
    Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    Cochrane CG; Müller-Eberhard HJ
    J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunofluorescent localization of the third and the fourth component of complement in synovial tissue from patients with rheumatoid arthritis.
    Rodman WS; Williams RC; Bilka PJ; Müller-Eberhard HJ
    J Lab Clin Med; 1967 Jan; 69(1):141-50. PubMed ID: 4163499
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].
    Stojan B; Hasler F
    Wien Klin Wochenschr; 1977 Nov; 89(21):713-6. PubMed ID: 919557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis.
    West CD; Winter S; Forristal J; McConville JM; Davis NC
    J Clin Invest; 1967 Apr; 46(4):539-48. PubMed ID: 4164258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.